SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001593034-20-000086
Filing Date
2020-11-05
Accepted
2020-11-05 16:54:34
Documents
16
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K endp-20201105.htm   iXBRL 8-K 48909
2 EX-99.1 a20200930ex991earnings.htm EX-99.1 882884
8 endoelogo1a.jpg GRAPHIC 186772
  Complete submission text file 0001593034-20-000086.txt   1375394

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT endp-20201105.xsd EX-101.SCH 2483
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT endp-20201105_cal.xml EX-101.CAL 771
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT endp-20201105_def.xml EX-101.DEF 3844
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT endp-20201105_lab.xml EX-101.LAB 27917
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT endp-20201105_pre.xml EX-101.PRE 14756
9 EXTRACTED XBRL INSTANCE DOCUMENT endp-20201105_htm.xml XML 10707
Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Filer) CIK: 0001593034 (see all company filings)

IRS No.: 680683755 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36326 | Film No.: 201291323
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences